Anest. intenziv. Med. 2010;21(5):227-228

Rekombinantní aktivovaný faktor VII v léčbě závažného krvácení u nehemofiliků - "vyšetřování (s využitím klinických randomizovných studií) skončilo, zapomeňte?"Editorial

Vladimír Černý

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černý V. Rekombinantní aktivovaný faktor VII v léčbě závažného krvácení u nehemofiliků - "vyšetřování (s využitím klinických randomizovných studií) skončilo, zapomeňte?". Anest. intenziv. Med. 2010;21(5):227-228.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. http://novonordisk-trials.com.
    2. www.ema.europa.eu.
    3. Vavra. K. A., Lutz, M.F., Smythe, M. A. Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants. Ann Pharmacother., 2010 44, 4, p. 718-726, Epub 2010 Mar 16. Go to original source... Go to PubMed...
    4. Seidlová, D., Blatný, J, Penka, M., Ovesná, P., Brabec, P., Ševčík, Ventruba, P., Černý, V. Rekombinantní aktivovaný faktor VII (rFVIIa) v léčbě závažného poporodního krvácení - data z registru UniSeven v České republice. Anest. intenziv. Med., 2010, 21, s. 229-238.
    5. Mannová Hillová, J., Seidlová, D., Mašek, M., Zimová, I., Ševčík, P. Aktivovaný rekombinantní faktor VII u závažného krvácení při těžkém poranění jater - kazuistiky. Anest. intenziv. Med., 2010, 21, s. 239-244.
    6. Dutton, R., Hauser, C., Boffard, K., Dimsitts, J., Bernard, G., Holcomb, J., Leppniemi, A., Tortella, B., Bouillon, B. CONTROL Steering Committee. Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding. Clin. Trials, 2009, 6, 5, p. 467-479. Go to original source... Go to PubMed...
    7. Deans, K. J., Minneci, P. C., Danner, R. L., Eichacker, P. Q., Natanson, C. Practice Misalignments in Randomized Controlled Trials: Identification, Impact, and Potential Solutions. Anesth. Analg., 2010, 111, p. 444-450. Go to original source... Go to PubMed...
    8. Rossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernandez-Mondejar, E., Hunt, B. J., Komadina, R., Nardi, G., Neugebauer, E., Ozier, Y., Riddez, L., Schultz, A., Stahel, P. F., Vincent, J. L., Spahn, D. R. Management of bleeding following major trauma: an updated European guideline. Crit. Care, 2010, 14, 2, R52. Epub 2010 Apr 6. PubMed Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.